C Mabedi1, C Kendig2, G Liomba3, C Shores4, F Chimzimu3, C Kampani3, R Krysiak3, S Gopal4. 1. University of Malawi, Department of Surgery, Kamuzu Central Hospital, Lilongwe, Malawi. 2. University of North Carolina, Chapel Hill, USA. 3. University of Malawi, Kamuzu Central Hospital, Department of Pathology, Lilongwe, Malawi. 4. University of North Carolina, Chapel Hill, USA ; UNC Project, Lilongwe, Malawi.
Abstract
AIM: Description of pathologic causes of cervical lymphadenopathy at Kamuzu Central Hospital. INTRODUCTION: The evaluation of cervical lymphadenopathy is a common diagnostic challenge facing clinicians. Previously at Kamuzu Central Hospital (KCH) tuberculosis (TB) was reported to be the most common cause of cervical lymphadenopathy However, no recent study has assessed this common diagnostic challenge in Malawi, particularly since the beginning of the HIV epidemic and the subsequent scale-up of antiretroviral therapy. METHODS: We conducted a cross-sectional study of all cervical lymph node specimens from the KCH pathology laboratory between 1 July 2011 and 28 February 2013 and describe patient age, gender, and pathologic diagnoses. RESULTS: Our search of the KCH pathology database yielded 179 cases. Of these, 143 (77%) were histologic specimens (open biopsy or core needle samples) while 34 (23%) were cytology specimens. The age range was from 0 to 76 years with a mean of 30 (SD: 19). In adults, the most common diagnosis was malignancy (n=41, 35%), while in children 15 cases each of malignancy and benign masses were diagnosed. Only 6 cases (5%) of TB were diagnosed in adults, and 4 cases (6%) of TB were diagnosed in children. CONCLUSION: Our study shows more malignancy and much less TB than a prior study of cervical lymphadenopathy at KCH. With the successful initiaion of the KCH Pathology Laboratory in 2011, we recommend biopsy or FNA early in the workup of cervical lymphadenopathy to prevent long delays in diagnosis and treatment of curable cancers.
AIM: Description of pathologic causes of cervical lymphadenopathy at Kamuzu Central Hospital. INTRODUCTION: The evaluation of cervical lymphadenopathy is a common diagnostic challenge facing clinicians. Previously at Kamuzu Central Hospital (KCH) tuberculosis (TB) was reported to be the most common cause of cervical lymphadenopathy However, no recent study has assessed this common diagnostic challenge in Malawi, particularly since the beginning of the HIV epidemic and the subsequent scale-up of antiretroviral therapy. METHODS: We conducted a cross-sectional study of all cervical lymph node specimens from the KCH pathology laboratory between 1 July 2011 and 28 February 2013 and describe patient age, gender, and pathologic diagnoses. RESULTS: Our search of the KCH pathology database yielded 179 cases. Of these, 143 (77%) were histologic specimens (open biopsy or core needle samples) while 34 (23%) were cytology specimens. The age range was from 0 to 76 years with a mean of 30 (SD: 19). In adults, the most common diagnosis was malignancy (n=41, 35%), while in children 15 cases each of malignancy and benign masses were diagnosed. Only 6 cases (5%) of TB were diagnosed in adults, and 4 cases (6%) of TB were diagnosed in children. CONCLUSION: Our study shows more malignancy and much less TB than a prior study of cervical lymphadenopathy at KCH. With the successful initiaion of the KCH Pathology Laboratory in 2011, we recommend biopsy or FNA early in the workup of cervical lymphadenopathy to prevent long delays in diagnosis and treatment of curable cancers.
Authors: Jerald Z Gong; Matthew J Snyder; Anand S Lagoo; Robin T Vollmer; Raj R Dash; John F Madden; Patrick J Buckley; Claudia K Jones Journal: Diagn Cytopathol Date: 2004-07 Impact factor: 1.582
Authors: Chiyembekezo Kachimanga; Atupere Phiri; Fatsani Manase; Katie Cundale; George Talama; Steve Kamiza; Lawrence Nazimera; Arnold Jumbe; Noel Kalanga; Nedson Fosiko; Leo Masamba; Emily B Wroe Journal: Malawi Med J Date: 2018-09 Impact factor: 0.875
Authors: Shiraz Khan; George Liomba; Nora E Rosenberg; Christopher Stanley; Cocxilly Kampani; Bal Mukunda Dhungel; Mina C Hosseinipour Journal: PLoS One Date: 2018-06-12 Impact factor: 3.240